Table 1.
Baseline characteristics of the study population (n = 177).
Figure 1.
Fibrin clot structure and platelet aggregation.
CAD patients without previous MI compared with CAD patients with previous MI on aspirin (ATF) assesed by turbidimetric clot assays (n = 172) and Multiplate® aggregometry (n = 174), respectively. Results are presented as median±IQR.
Figure 2.
Fibrin clots from age- and sex-matched patients without previous myocardial infarction using pooled plasma (n = 20 in each group). Clots shown at ×30,000 magnification.
Figure 3.
Fibrin clots from age- and sex-matched patients with previous myocardial infarction on aspirin (aspirin treatment failure) using pooled plasma (n = 20 in each group). Clots shown at ×30,000 magnification.
Table 2.
Correlations between fibrin clot structure parameters and platelet aggregation in patients with coronary artery disease.